Carl Hansen

Dr. Carl Hansen is shaping the future of biological sciences as a Professor at Florida Atlantic University. With a Ph.D. from Pennsylvania State University, Dr. Hansen is at the forefront of research in angiogenesis, a critical process involving the growth of new blood vessels from pre-existing ones. His work is particularly focused on the intricate mechanisms of G-protein signaling and its implications in diseases such as retinopathy and cancer, where dysregulation of angiogenesis plays a pivotal role. Dr. Hansen's research delves into the function of the Gγ11 protein, which acts as an angiostatic switch. This protein is crucial in maintaining endothelial cell quiescence, thereby preventing the excessive growth of blood vessels. By understanding this mechanism, Dr. Hansen aims to uncover new therapeutic targets for diseases characterized by abnormal vessel growth. His innovative approach not only contributes to the scientific community but also holds promise for developing novel treatments for angiogenesis-related conditions. In collaboration with Dr. Janet Robishaw's laboratory, Dr. Hansen's work exemplifies the power of interdisciplinary research. Together, they are unraveling the complexities of cell signaling pathways that govern angiogenesis. This partnership enhances the depth and breadth of their findings, offering new insights into the regulation of blood vessel formation. Dr. Hansen's dedication to advancing our understanding of these biological processes underscores his commitment to improving human health through scientific discovery. Beyond his research, Dr. Hansen is deeply invested in mentoring the next generation of scientists. He is known for his engaging teaching style and his ability to inspire students to pursue careers in the life sciences. His contributions to both research and education make him a valuable asset to Florida Atlantic University and the broader scientific community.